Manila, 1605, Philippines
NCT Number: NCT00874159
A Survey to Evaluate Diabetes Management, Control, Complications and Psychosocial Aspects of Diabetic Patients in Philippines
This study is conducted in Asia. The aim of this observational study is to describe the diabetes management, control status and complication profile in a diabetic population of Philippines.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Diabetic patients registered in the particular centre for more than 12 months
- Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit
- Patients willing to sign informed consent form
Exclusion criteria
- Repetition of any patient as patients should not be included twice for any reason
- Unwilling to participate or unable to comply with protocol requirements
Treatment and study plan
No treatment given
OtherSubject will only fill out a questionaire when entering the observational study.
Primary outcomes
-
Mean age of onset of type 1 diabetes mellitus
Time frame: at baseline visit/study start
-
Mean age of onset of type 2 diabetes mellitus
Time frame: at baseline visit/study start
-
Mean duration of treatment of type 2 DM
Time frame: at baseline visit/study start
-
Percentage of patients on Insulin therapy
Time frame: at baseline visit/study start
-
Percentage of patients on OAD therapy
Time frame: at baseline visit/study start
-
Mean duration of diabetes in type 1 and type 2 patients respectively
Time frame: at baseline visit/study start
-
Mean FPG of diabetic patients
Time frame: at baseline visit/study start
-
Mean PPG of diabetic patients
Time frame: at baseline visit/study start
-
Mean HbA1c of diabetic patients
Time frame: at baseline visit/study start
-
Percentage of diabetic patients with HbA1c target below 7.0%
Time frame: at baseline visit/study start
-
Percentage of diabetic patients with HbA1c target below 6.5%
Time frame: at baseline visit/study start
-
Percentage of diabetic patients having dyslipidemia and hypertension
Time frame: at baseline visit/study start
-
Percentage of diabetic patients having cardiovascular complications
Time frame: at baseline visit/study start
-
Percentage of diabetic patients having peripheral vascular disease
Time frame: at baseline visit/study start
-
Percentage of diabetic patients having diabetic nephropathy
Time frame: at baseline visit/study start
-
Percentage of diabetic patients having diabetic eye complications
Time frame: at baseline visit/study start
Secondary outcomes
-
Patients' perception will be analysed through Patient questionnaire measuring: Psychological well-being, Quality of life, Patients' compliant to treatment
Time frame: at baseline visit/study start
-
Physician perception of diabetes and its management will be analysed through Physician questionnaire measuring awareness about:o HbA1c test and its goal,Anti-diabetic treatment,Barriers towards optimum diabetes control
Time frame: at baseline visit/study start
-
Duration of diabetes associated with highest number of diabetic complications
Time frame: at baseline visit/study start
-
Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, nephropathy and retinopathy)
Time frame: at baseline visit/study start
Sponsors and collaborators
Lead sponsor
Novo Nordisk A/S
Industry
Registry information
Official study title
DiabCare Asia 2008 Philippines A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Philippines & To Evaluate Perceptions and Practices of Physicians & Patients About Diabetes Management in Philippines
Acronym: DiabCare Asia
Important dates
- Study start
- 2009
- Primary completion
- 2009
- Study completion
- 2009
- First posted
- Apr 2, 2009
- Registry last updated
- Nov 2, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes
NCT04769167
Autoimmune Diseases, Cardiovascular Abnormalities
St Louis, Missouri, United States
View Trial DetailsObservational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
NCT00671008
Autoimmune Diseases, Diabetes
Sarajevo, Bosnia and Herzegovina
View Trial DetailsObservational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
NCT00655200
Autoimmune Diseases, Diabetes
Manila, Philippines
View Trial DetailsA Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Korea
NCT00918151
Autoimmune Diseases, Diabetes
Seoul, South Korea
View Trial Details